Mark Molloy

Professor

University of Sydney

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Microbiology Microbiology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Mark Molloy is a faculty member at the University of Sydney in Australia. His research focuses on areas such as cancer biology, gut microbiome interactions, and the therapeutic potential of microRNA. Recent publications include studies on early low-grade bowel polyps, the oral microbiome in head and neck cancer, and the complexities of chronic polypharmacy in aging. Through his work, he aims to enhance understanding of oncogenic drivers and the impact of microbiomes on health outcomes.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (37)

Romain Guerillot

Institut Pasteur

FRANCE

Mark Molloy

Research Interests

Explore related searches

Contact this professor

About

Articles (30)

Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size

Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future Directions

Therapeutic potential of synthetic microRNA mimics based on the miR-15/107 consensus sequence.

Gut Mucosal Microbiome of Patients With Low-Grade Adenomatous Bowel Polyps

Proteome profiling of enriched membrane-associated proteins unraveled a novel sophorose and cello-oligosaccharide transporter in Trichoderma reesei

Immunogenic cell death in colorectal cancer: a review of mechanisms and clinical utility.

A Validated Assay to Quantify Osimertinib and Its Metabolites, AZ5104 and AZ7550, from Microsampled Dried Blood Spots and Plasma

Therapeutic drug monitoring of osimertinib in EGFR mutant non‐small cell lung cancer by dried blood spot and plasma collection: A pilot study

Proteogenomic Characterization of Early Intrahepatic Recurrence after Curative-Intent Treatment of Colorectal Liver Metastases

Chronic polypharmacy, monotherapy, and deprescribing: Understanding complex effects on the hepatic proteome of aging mice.

Decorin, an exercise-induced secretory protein, is associated with improved prognosis in breast cancer patients but does not mediate anti-tumorigenic tissue crosstalk in mice.

IbpAB small heat shock proteins are not host factors for bacteriophage φX174 replication

The role of HnrnpF/H as a driver of oligoteratozoospermia

Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria

Plasma Aβ42/40 ratio, p-tau181, GFAP and NFL across the Alzheimer’s disease continuum

CD11c + and IRF8 + cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy

Inhibition of autophagy initiation: A novel strategy for oral squamous cell carcinomas.

Mucosal Microbiome in Patients with Early Bowel Polyps: Inferences from Short-Read and Long-Read 16S rRNA Sequencing

One Step Forward with Dry Surface Biofilm (DSB) of Staphylococcus aureus: TMT-Based Quantitative Proteomic Analysis Reveals Proteomic Shifts between DSB and Hydrated Biofilm

Overlapping genes in natural and engineered genomes

Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ‐PET, neurodegeneration, and cognition

Proteomic analysis of whole blood using volumetric absorptive microsampling for precision medicine biomarker studies

ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ

Proteomic and transcriptomic analysis of Microviridae φX174 infection reveals broad upregulation of host Escherichia coli membrane damage and heat shock responses

Identification of a novel ciprofloxacin tolerance gene, aciT, which contributes to filamentation in Acinetobacter baumannii

The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?

Genomic, Microbial and Immunological Microenvironment of Colorectal Polyps

Proteome analysis of human adipocytes identifies depot-specific heterogeneity at metabolic control points

Metformin, Microbiome and Protection Against Colorectal Cancer

The Gut Microbiome and Gastrointestinal Toxicities in Pelvic Radiation Therapy: A Clinical Review

Collaborators (37)

Romain Guerillot

Snehal Jadhav

Arthur Chien

Varsha Naidu, PhD

Ralph Martins

Honghua Hu

Bhumika Shah

Chahaya Gauci

Nicholas P. West

Matthew McKay

Lauren Gray

Helena Nevalainen

jørgen wojtaszewski

Alison Hogan

Natalie Grima

Julie Midtgaard

Hamid Reza Sohrabi

Tania Sorrell

Stephanie Rayner

Flora Cheng

Abhay Singh

Marit Hjorth

Anand Deva

Timothy P. Stinear

Alexander Engel

Sonika Tyagi

Stephanie Nagy

Shu Yang

Karen Vickery

Marco Morsch

Sarah Baines

Paul Jaschke

Pratishtha Chatterjee

Leila Jebeli

Shila Ghazanfar

Towia Libermann

Albert Lee

Make your next move.